IAA
MRNA icon

Independent Advisor Alliance’s Moderna MRNA Stock Holding History

Independent Advisor Alliance’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-5,726
Closed -$696K – 683
2023
Q2 		$696K Hold
5,726
– – 0.03% 357
2023
Q1 		$879K Buy
+5,726
New +$945K 0.04% 306
2022
Q4 		– Sell
-1,846
Closed -$218K – 546
2022
Q3 		$218K Sell
1,846
-150
-8% -$22.8K 0.01% 560
2022
Q2 		$285K Sell
1,996
-161
-7% -$23K 0.02% 498
2022
Q1 		$372K Sell
2,157
-404
-16% -$68K 0.02% 467
2021
Q4 		$650K Sell
2,561
-5,986
-70% -$1.75M 0.03% 336
2021
Q3 		$3.29M Sell
8,547
-11,491
-57% -$4.24M 0.18% 114
2021
Q2 		$4.71M Buy
20,038
+779
+4% +$139K 0.26% 95
2021
Q1 		$2.52M Sell
19,259
-2,518
-12% -$365K 0.15% 134
2020
Q4 		$2.27M Buy
21,777
+17,826
+451% +$1.8M 0.15% 124
2020
Q3 		$268K Buy
+3,951
New +$275K 0.02% 404

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return

Independent Advisor Alliance's MRNA Position: Q3 2023 in Review

Independent Advisor Alliance sold out of Moderna (MRNA) in Q3 2023, closing a stake of 5,726 shares — an estimated $696K sold.

Independent Advisor Alliance first reported a position in MRNA in Q3 2020 and held it in 11 quarters. The position peaked at $4.71M in Q2 2021. 889 funds tracked by Wall St. Rank hold MRNA as of Q3 2023.

  • Independent Advisor Alliance reported no remaining Moderna position as of Q3 2023 after selling out during the quarter.
  • Independent Advisor Alliance sold 5,726 Moderna shares in Q3 2023, an estimated $696K.
  • Independent Advisor Alliance first reported a position in Moderna in Q3 2020 and held it in 11 quarters.
  • Independent Advisor Alliance's Moderna position peaked at $4.71M in Q2 2021.
  • 889 funds tracked by Wall St. Rank held Moderna as of Q3 2023.

Based on Independent Advisor Alliance's 13F filing for Q3 2023, filed 24 Oct 2023.